Nanotechnology for nanomedicine and delivery of drugs

Current Pharmaceutical Design

Volumn 14, Issue 22, 2008, Pages 2184-2200

  Venugopal, J ^a   Prabhakaran, Molamma P ^a   Low, Sharon ^b   Choon, Aw Tar ^b,c,d   Zhang, Y Z ^a   Deepika, G ^a   Ramakrishna, S ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b StemLife Sdn Bhd   (Malaysia)

^c CHANGI GENERAL HOSPITAL   (Singapore)

^d MONASH UNIVERSITY MALAYSIA   (Malaysia)

Author keywords

Cell adhesion molecules; Drug delivery; Electrospinning; Nanofibers; Polymer; Stem cells; Tissue engineering

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; BIOCERAMICS; CADHERIN; CHITOSAN; COLLAGEN; FIBRIN; GELATIN; HUMAN GROWTH HORMONE; HYALURONIC ACID; HYDROXYAPATITE; INTEGRIN; MACROGOL; MICROSPHERE; MOLECULAR SCAFFOLD; NANOFIBER; NANOMATERIAL; NANOSPHERE; PEGINTERFERON; POLYCAPROLACTONE; POLYGLACTIN; POLYLYSINE; POLYMER; POLYURETHAN; SELECTIN; STEROID; SYNDECAN; UNINDEXED DRUG; VACCINE;

BIOCOMPATIBILITY; BIODEGRADABILITY; BIOMECHANICS; BLOOD VESSEL TRANSPLANTATION; BONE DEFECT; BONE REGENERATION; BONE REMODELING; BONE TRANSPLANTATION; CARTILAGE INJURY; CARTILAGE TRANSPLANTATION; CELL ADHESION; CLINICAL TRIAL; COMPOSITE MATERIAL; CONTROLLED DRUG RELEASE; DRUG DELIVERY SYSTEM; DRUG MEGADOSE; HUMAN; MUSCLE DISEASE; NANODEVICE; NANOENGINEERING; NANOFABRICATION; NANOMEDICINE; NANOTECHNOLOGY; NEOPLASM; NERVE TRANSPLANTATION; NONHUMAN; OSTEOARTHRITIS; PARTICLE SIZE; PERIPHERAL NERVE INJURY; POROSITY; PRIORITY JOURNAL; PROTEIN FUNCTION; REGENERATIVE MEDICINE; REVIEW; RHEUMATOID ARTHRITIS; STEM CELL TRANSPLANTATION; STENT; TISSUE ENGINEERING; TISSUE REGENERATION; WOUND DRESSING; WOUND HEALING;

CELL ADHESION MOLECULES; DRUG DELIVERY SYSTEMS; NANOMEDICINE; NANOSTRUCTURES; NANOTECHNOLOGY; TISSUE ENGINEERING;

EID: 52949140576     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161208785740180     Document Type: Review

References (187)

1. Logothetidis S. Nanotechnology in medicine: the medicine of tomorrow and nanomedicine. Hippokratia 2006; 10: 7-21.
2. Venugopal J, Low S, Choon AW, Ramakrishna S. Interaction of cells and nanofiber scaffolds. J Biomed Mater Res B 2008; 84: 34-48.
3. Zuwei M, Ramakrishna S. Nanostructured Extracellular Matrix, Encyclopedia of Nanoscience and Nanotechnology, American Scientific Publishers, California, USA, 2004; 7: 641-55.
4. Kumbar SG, Nair LS, Laurencin CT. Polymeric nanofibers as novel carriers for the delivery of therapeutic molecules. J Nanosci Nanotech 2006; 6:1-17.
5. Farokhzad OC, Langer R. Nanomedicine: developing smarter therapeutic- and diagnostic modalities. Adv Drug Deliv Rev 2006; 58: 1456-9.
6. Hutmacher DW. Scaffolds in tissue engineering bone and cartilage. Biomaterials 2000; 21: 2529-43.
7. Peter SJ, Miller MJ, Yaszemski AG, Mikos AG. Polymer concepts in tissue engineering. J Biomed Mater Res 1998; 43: 422-7.
8. Smith LA, Ma PX. Nano-fibrous scaffolds for tissue engineering. Colloids and Surfaces B: Biointerfaces 2004; 39: 125-31.
9. Zhang YZ, Huang ZM, Xu X, Lim CT, Ramakrisbna S. Preparation of core-shell structured PCL-r-gelatin bi-component nanofibers by coaxial electrospinning. Chem Mater 2004; 16: 3406-9.
10. Kidoaki S, Kwon K, Matsuda T. Mesoscopic spatial designs of nano- and micro meshes for tissue-engineering matrix and scaffold based on newly devised multilayering and mixing electrospinning techniques. Biomaterials 2005; 26: 37-46.
11. Piskin E. Biodegradable polymeric matrices for bioartificial implants. Int J Artif Organs 2002; 25: 434-40.
12. Woo RK, Jenkins DD, Greco RS. Biomaterials: Historical overview and current directions, In: Greco RS, Prinz FB, Lane Smith, R. Eds, Nanoscale Technology in Biological Systems. CRC Press, London, 2005; 1-24.
13. Gan Z, Luang Q, Jing X. Enzymatic degradation of poly(ε-caprolactone) film in phosphate buffer solution containing lipases. Polym Degrad Stab 1997; 56: 209-13.
14. Kim BS, Mooney DJ. Development of biocompatible synthetic extracellular matrices for tissue engineering. Trends Biotechnol 1998; 16: 224-30.
15. Inai R, Kotaki M, Ramakrishna S. Structure and properties of electrospun PLLA single nanofibres. Nanotechnology 2005; 16: 208-13.
16. Boland ED, Wnek GE, Simpson DG, Pawlowski KJ. Tailoring tissue engineering scaffolds using electrostatic processing techniques: a study poly(glycolic acid) electrospinning. J Macromol Sci Pure Appl Chem 2001; A38: 1231-43.
17. Zong X, Ran S, Fang D, Hsiao BS, Chu B. Control of structure, morphology and property in electrospun poly(glycolide-co-lactide) non-woven membrane via post-draw treatment. Polymer 2003; 44: 4959-67.
18. Venugopal J, Vadgama P, Ramakrishna S. Biocomposite nanofibers and osteoblasts for bone tissue engineering. Nanotechnology 2007; 18: 511-8.
19. Xu CY, Inai R, Ramakrishna S. Aligned biodegradable nanofiberous structure: a potential scaffold for blood vessel engineering. Biomaterials 2004; 25: 877-86.
20. Huang L, Nagapundi K, Chaikof EL. Engineered collagen PEO nanofibers and fabrics. J Biomater Sci Polym Edn 2001; 12: 979-93.
21. Pedicini A, Farris RJ. Mechanical behavior of electrospun polyurethane. Polymer 2003; 44: 6857-63.
22. Zuwei M, Kotaki M, Yong T, Wei H, Ramakrishna S. Surface engineering of electrospun polyethylene terephthalate (PET) nanofibers towards development of a new material for blood vessel engineering. Biomaterials 2005; 26: 2527-36.
23. Ding B, Kim HY, Lee SC, Park SJ, Choi KJ. Preparation and characterization of a nanoscale poly(vinyl alcohol) fiber aggregate produced by an electrospinning method. J Polym Sci Pt B-Polym Phys 2002; 40: 1261-8.
24. Megelski S, Stephens JS, Chase DB, Rabolt JF. Micro and nanostructured surface morphology on electrospun polymer fibers. Macromolecules 2002; 35: 8456-66.
25. Bognitzki M, Czado W, Frese T, Grenier A, Wendorff JH. Nanostructured fibers via electrospinning. Adv Mater 2001; 13: 70-2.
26. Bhattarai N, Cha DI, Bhattarai SR, Khil MS, Kim HY. Biodegradable electrospun mat: novel block copolymer of Poly(p-dioxanoneco-L-lactide) -block-poly(ethylene glycol). J Polym Sci Pt B-Polym Phys 2003; 41: 1955-64.
27. Casper CL, Stephens JS, Tassi NG, Chase DB, Rabolt JF. Controlling surface morphology of electrospun polystyrene fibers: Effect of humidity and molecular weight in the electrospinning process. Macromolecules 2004; 37: 573-8.
28. Matthews JA, Wnek GE, Simpson DG, Bowlin GL. Electrospinning of collagen nanofibers. Biomacromolecules 2002; 3: 232-8.
29. Ohkawa K, Cha D, Kim H, Nishida A, Yamamoto H. Electrospinning of Chitosan. Macromol Rapid Commun 2004; 25: 1600-5.
30. Zhang YZ, Ramakrishna S, Huang ZM. Electrospinning of gelatin fibers and Gelatin/PCL composite fibrous scaffolds. J Biomed Mater Res 2005; 72B: 156-65.
31. Wnek GE, Carr ME, Simpson DG, Bowlin GL. Electrospinning of nanofiber fibrinogen structures. Nano Lett 2003; 3: 213-16.
32. Luu YK, Kim K, Hsiao BS, Chu B, Hadjiargyrou M. Development of a nanostructured DNA delivery scaffold via electrospinning of PLGA and PLA-PEG block copolymers. J Control Release 2003; 89: 341-53.
33. Stankus JJ, Guan J, Wagner WR. Fabrication of biodegradable elastomeric scaffolds with sub-micron morphologies. J Biomed Mater Res 2004; 70A: 603-14.
34. Zhong SP, Teo WE, Zhu X, Beuerman R, Ramakrishna S, Yung LY. Formation of collagen-glycosaminoglycan blended nanofibrous scaffolds and their biological properties. Biomacromolecules 2005; 6: 2998-3004.
35. Li M, Guo Y, Wei Y, Lelkes PI. Electrospinning polyanilinecontained gelatin nanofibers for tissue engineering applications. Biomaterials 2006; 27: 2705-15.
36. Min BM, Lee G, Park WH. Electrospinning of silk fibroin nanofibers and its effect on the adhesion and spreading of normal human keratinocytes and fibroblasts in vitro. Biomaterials 2004; 25: 1289-97.
37. Venugopal JR, Low S, Choon AT, Kumar AB, Ramakrishna S. Nanobioengineered electrospun composite nanofibers and osteoblasts for bone regeneration. Artif Organs 2008; 32: 388-97.
38. Kwon IK, Matsuda T. Co-Electrospun nanofiber fabrics of poly(Llactide-co-ε-caprolactone) with type I collagen or heparin. Biomacromolecules 2005; 6: 2096-105.
39. Chew SY, Wen J, Yim EKF, Leong KW. Sustained release of proteins from electrospun biodegradable fibers. Biomacromolecules 2005; 6: 2017-24.
40. Meng W, Kim SY, Jiang Y, Chul J, Naoki K, Inn-Kyu K. Electrospun PHBV/ collagen composite nanofibrous scaffolds for tissue engineering. J Biomater Sci Poly Edn 2007; 18: 81-94.
41. Chew SY, Mi R, Hoke A, Leong KW. Aligned protein-polymer composite fibers enhance nerve regeneration: a potential tissue-engineering platform. Adv Func Mater 2007; 17: 1288-96.
42. Venugopal JR, Zhang YZ, Ramakrishna S. In vitro culture of human dermal fibroblasts on electrospun polycaprolactone collagen nanofibrous membrane. Artif Organs 2006; 30: 440-6.
43. Park KE, Kang HK, Lee SJ, Min BM, Park WH. Biomimetic nanofibrous scaffolds: preparation and characterization of PGA/chitin blend nanofibers. Biomacromolecules 2006; 7: 635-43.
44. Kim HW, Song JH, Kim HE. Nanofiber generation of gelatin-hydroxyapatite biomimetics for guided tissue regeneration. Adv Func Mat 2005; 15: 1988-94.
45. Fujihara K, Kotaki M, Ramakrishna S. Guided bone regeneration membrane made of polycaprolactone/calcium carbonate composite nano-fibers. Biomaterials 2005; 26: 4139-47.
46. Ito Y, Hasuda H, Kamitakahara M, Ohtsuki C, Tanihara M, Kang IK, et al. A composite of hydroxyapatite with electrospun biodegradable nanofibers as a tissue engineering material. J Biosci Bioeng 2005; 100: 43-9.
47. Kim HW, Lee HH, Knowles JC. Electrospinning biomedical nanocomposite fibers of hydroxyapatite/poly(lactic acid) for bone regeneration. J Biomed Mater Res 2006; 79A: 643-9.
48. Deng XL, Xu MM, et al. Electrospun PLLA/MWNTs/HA hybrid nanofiber scaffolds and their potential in dental tissue engineering. Key Eng Mater 2007; 330-332: 393-396.
49. Venugopal J, Low S, Choon AT, Bharath Kumar A, Ramakrishna S. Electrospun modified nanofibrous scaffolds for the mineralization of osteoblast cells. J Biomed Mater Res 2008; 85A: 408-17.
50. Buttafoco L, Kolkman NG, Feijen J. Electrospinning of collagen and elastin for tissue engineering applications. Biomaterials 2006; 27: 724-34.
51. Stitzel J, Liu J, Lee SJ, Komura M, Berry J, Yoo JJ, et al. Controlled fabrication of a biological vascular substitute. Biomaterials 2006; 27: 1088-94.
52. Li M, Lelkes PI. Co-electrospun poly(lactide-co-glycolide), gelatin, and elastin blends for tissue engineering scaffolds. J Biomed Mater Res 2006; 79A: 963-73.
53. He W, Ma Z, Yong T, Teo WE, Ramakrishna S. Fabrication of collagen-coated biodegradable polymer nanofiber mesh and its potential for endothelial cells growth. Biomaterials 2005; 26: 7606-15.
54. Li C, Vepari C, Jin HJ, Kim HJ, Kaplan DL. Electrospun silk-BMP-2 scaffolds for bone tissue engineering. Biomaterials 2006; 27: 3115-24.
55. Burger C, Hsiao BS, Chu B. Nanofibrous materials and their applications. Annu Rev Mater Res 2006; 36: 333-68.
56. VisionGain, Drug Delivery, New Technologies in the Global Market; 2003.
57. Goldberg M, Langer R, Jia X. Nanostructured materials for applications in drug delivery and tissue engineering. J Biomater Sci Polymer Edn 2007; 18: 241-68.
58. Peng T, Cheng YL. PNIPAAm and PMAA co-grafted porous PE membranes: living radical co-grafting mechanism and multi-stimuli responsive permeability. Polymer 2001; 42: 2091-100.
59. Langer R. Drug delivery and targeting. Nature 1998; 392: 5-10.
60. Langer R, Tirrell DA. Designing materials for biology and medicine. Nature 2004; 428: 487-92.
61. Venugopal J, Ramakrishna S. Nanotechnology: A challenge in health care, Proceedings of International Forum on Biomedical Textile Materials, Donghua University, Donghua University Press, Shanghai, 30th May - 2nd June 2007; 121-8.
62. Laurencin CT, Koh HJ, Langer R. Controlled release using a new bioerodible polyphosphazene matrix system. J Biomed Mater Res 1987; 21: 1231-46.
63. Lakshmi S, Katti DS, Laurencin CT. Biodegradable polyphosphazenes for drug delivery applications. Adv Drug Delivery Rev 2002; 55: 467-82.
64. Zhang YZ, Su B, Lim CT, Venugopal J, Ramakrishna S. Biomimetic and bioactive nanofibrous scaffolds by electrospinning of composite materials. Int J Nanomed 2007; 2: 623-38.
65. Loscertales IG, Barrero A, Marquez M, Ganan-Calvo AM. Micro/nano encapsulation via electrified coaxial liquid jets. Science 2002; 295: 1695-8.
66. Sun Z, Zussman E, Yarin AL, Greiner A. Compound core-shell polymer nanofibers by co-electrospinning. Adv Mater 2003; 15: 1929-32.
67. Sokolsky-Papkov M, Agashi K, Domb AJ. Polymer carriers for drug delivery in tissue engineering. Adv Drug Deliv Rev 2007; 59: 187-206.
68. Palovuori R. Regulation of cell-cell adhesion and actin cytoskeleton in nontransformed and transformed epithelial cells. Department of Pathology, Biocenter Oulu, University of Oulu, Finland; 2003.
69. http://ntri.tamuk.edu/homepage-ntri/lectures/protein/ junction1.html.
70. Tirrell M, Kokkoli E, Biesalski M. The role of surface science in bioengineered materials. Surf Sci 2002; 500: 61-83.
71. Isacke CM, Horton MA. Adhesion Molecule Families. The Adhesion Molecule, Second ed, Academic Press, New York, 7-32.
72. Burridge K, Fath K, Kelly T, Nuckolls G, Turner C. Focal adhesions: transmembrane junctions between the extracellular matrix and the cytoskeleton. Annu Rev Cell Biol 1988; 4: 487-525.
73. Yamada KM, Miyamoto S. Integrin transmembrane signaling and cytoskeletal control. Curr Opin Cell Biol 1995; 7: 681-9.
74. Takeichi, M. Cadherins in cancer: implications for invasion and metastasis. Curr Opin Cell Biol 1993; 5: 806-11.
75. Knudsen KA, Frankowski C, Johnson KR, Wheelock MJ. A role for cadherins in cellular signaling and differentiation. J Cell Biochem Suppl 1998; 30-31: 168-76.
76. Fagotto F, Gumbiner BM. Cell contact-dependent signaling. Dev Biol 1996; 180: 445-54.
77. Graves BJ, Crowther RL, Chandran C, Rumberger JM, Li S, Huang KS. Insight into E-selectin/ligand interaction from the crystal structure and mutagenesis of the lec/EGF domains. Nature 1994; 367: 532-8.
78. Carey DJ. Syndecans: multifunctional cell-surface co-receptors. Biochem J 1997; 327 (Pt 1): 1-16.
79. Morgan MR, Humphries MJ, Bass MD. Synergistic control of cell adhesion by integrins and syndecans. Nat Rev Mol Cell Biol 2007; 12: 957-69.
80. Curtis A, Wilkinson C. Topographical control of cells. Biomaterials 1997; 18: 1573-83.
81. Caplan AI, Elyaderani M, Mochizuki Y, Wakitani S, Goldberg VM. Principles of cartilage repair and regeneration. Clin Orthop Relat Res 1997; 342: 254-69.
82. Solchaga LA, Caplan AI. Hyaluronic acid-based polymers as cell carriers for tissue-engineered repair of bone and cartilage J Orthop Res 1999; 17: 205-13.
83. Anthansiou KA, Niederauer GG, Agarwal CM. Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid/ polyglycolic acid copolymers. Biomaterials 1996; 17: 93-102.
84. Li WJ, Laurencin CT, Ko FK. Electrospun nanofibrous structure: a novel scaffold for tissue engineering. J Biomed Mater Res 2002; 60: 613-21.
85. Kolacna L, Bakesova F, Pelouch V. Biochemical and biophysical aspects of collagen nanostructure in extracellular matrix. Physiol Res 2007; 56(Suppl 1): S51-60.
86. Sakiyama-Elbert SE, Hubbell JA. Development of fibrin derivatives for controlled release of heparin-binding growth factors. J Control Release 2000; 65: 389-402.
87. Pieper JS, Hafmans T, van Wachem PB, van Kuppevelt TH. Loading of collagen-heparan sulfate matrices with bFGF promotes angiogenesis and tissue generation in rats. J Biomed Mater Res 2002; 62: 185-94.
88. Nettles DL, Elder SH, Gilbert JA. Potential use of chitosan as a cell scaffold material for cartilage tissue engineering. Tissue Eng 2002; 8: 1009-16.
89. Li Z, Ramay HR, Hauch KD, Xiao D, Zhang M. Chitosan-alginate hybrid scaffolds for bone tissue engineering. Biomaterials 2005; 26: 3919-28.
90. Perets A, Baruch Y, Cohen S. Enhancing the vascularization of three-dimensional porous alginate scaffolds by incorporating controlled release basic fibroblast growth factor microspheres. J Biomed Mater Res 2003; 65A: 489-97.
91. Leach JB, Bivens KA, Patrick CW, Schmidt CE. Photocrosslinked hyaluronic acid hydrogels: natural, biodegradable tissue engineering scaffolds. Biotechnol Bioeng 2003; 82: 578-89.
92. Chung HJ, Park TG. Surface engineered and drug releasing pre-fabricated scaffolds for tissue engineering. Adv Drug Deliv Rev 2007; 59: 249-62.
93. Pandit A, Ashar R, Feldman D, Thomson A. Investigation of acidic fibroblast growth factor delivered through a collagen scaffold for the treatment of full-thickness skin defects in a rabbit model. Plast Reconstr Surg 1998: 101: 766-75.
94. Soker S, Machado M, Atla A. Systems for therapeutic angiogenesis in tissue engineering. World J Urol 2000; 18: 10-8.
95. Zhang YZ, Lim CT, Ramakrishna S, Huang ZM. Recent development of polymer nanofibers for biomedical and biotechnological applications. J Mater Sci Mater Med 2005; 16: 933-46.
96. Khil MS, Cha DI, Kim IS, Bhattarai N. Electrospun nanofibrous polyurethane membrane as wound dressing. J Biomed Mater Res 2003; 67B: 675-9.
97. Bhattarai SR, Bhattarai N, Kim HY. Novel biodegradable electrospun membrane: scaffold for tissue engineering. Biomaterials 2004; 25: 2595-602.
98. Rho KS, Jeong L, Park YJ, Hong SD, Park WH, Min BM. Electrospinning of collagen nanofibers: effects on the behavior of normal human keratinocytes and early-stage wound healing. Biomaterials 2006; 27: 1452-61.
99. Venugopal J, Ramakrishna S. Biocompatible nanofiber matrices for the engineering of a dermal substitute for skin regeneration. Tissue Eng 2005; 11: 847-54.
100. Zhang YZ, Venugopal J, Huang ZM, Lim CT, Ramakrishna S. Characterization of the surface biocompatibility of the electrospun PCL-collagen nanofibers using fibroblasts. Biomacromolecules 2005; 6: 2583-9.
101. Khan YM, Katti DS, Laurencin CT. Novel polymer-synthesized ceramic composite-based system for bone repair: an in vitro evaluation. J Biomed Mater Res 2004; 69A: 728-37.
102. Thomas V, Jagani S, Jose MV, Nyairo E. Electrospun bioactive nanocomposite scaffolds of polycaprolactone and nanohydroxyapatite for bone tissue engineering. J Nanosci Nantechnol 2006; 6: 487-93.
103. Thomas V, Dean DR, Vohra YK. Nanostructured biomaterials for regenerative medicine. Curr Nanosci 2006; 2: 155-77.
104. Thomas V, Vohra YK. Nanostructured biocomposite scaffolds based on collagen coelectrospun with nanohydroxyapatite. Biomacromolecules 2007; 8: 631-7.
105. Hong Z, Zhang P, Jing X. Nano-composite of poly(l-lactide) and surface grafted hydroxyapatite: Mechanical properties and biocompatibility. Biomaterials 2005; 26: 6296-304.
106. Wahl DA, Sachlos E, Liu C, Czernuszka JT. Controlling the processing of collagen-hydroxyapatite scaffolds for bone tissue engineering. J Mater Sci Mater Med 2007; 18: 201-9.
107. Woo KM, Chen VJ, Ma PX. Nano-fibrous scaffolding architecture selectively enhances protein adsorption contributing to cell attachment. J Biomed Mater Res 2003; 67A: 531-7.
108. Du C, Cui FZ, Zhu XD, de Groot K. Three-dimensional nano-HAp/collagen matrix loading with osteogenic cells in organ culture. J Biomed Mater Res 1999; 44: 407-15.
109. Buckwalter JA. Articular cartilage injuries. Clin Orthop 2002; 402: 21-37.
110. Solomon L, Warwick DJ, Nayagam S. Apley's system of orthopaedics and fractures. New York: Oxford University Press, 2001.
111. Hayes DW Jr, Brower RL, John KJ. Articular cartilage. Anatomy, injury, and repair. Clin Podiatr Med Surg 2001; 18: 35-53.
112. Pacifici M, Koyama E, Gentili C. Development of articular cartilage: what we know about it and how may it occur? Connect Tissue Res 2000; 41: 175-84.
113. Zhu W, Latridis JC, Hlibczuk V, Ratcliffe A, Mow VC. Determination of collagen-proteoglycan interactions in vitro. J Biomech 1996; 29: 773-83.
114. Mow VC, Hayes WC. Basic orthopedic mechanics. New York: Raven Press, 1991; 143-91.
115. Buckwalter JA, Mankin HJ. Articular cartilage repair and transplantation. Arthritis Rheum 1998; 41: 1331-42.
116. Bugbee WD. Fresh osteochondral allografts. J knee Surg 2002; 15: 191-5.
117. Jakobs RP, Franz T, Manil-Varlet P. Autologous osteochondral grafting in the knee: indication, results, and reflections. Clin Orthop 2002; 401: 170-84.
118. Tom JA, Rodeo SA. Soft tissue allografts for knee reconstruction in sports medicine. Clin Orthop 2002; 402: 135-56.
119. Peterson L, Minas T, Brittberg M, Nilsson A, Sjorgren-Jansson E, Lindahl A. Two- to 9-year outcome after autologous chondrocyte transplantation of the knee. Clin Orthop Relat Res 2000; 374: 212-34.
120. Hollander AP, Abatangelo G. Maturation of tissue engineered cartilage implanted in injured and osteoarthritic human knees. Tissue Eng 2006; 12: 1-12.
121. Mendler M, Eich-Bender SG, Vaughan L, Bruckner P. Cartilage contains mixed fibrils of collagen type II, IX and XI. J Cell Biol 1989; 108: 191-7.
122. Aigner T, Stove J. Collagens-major component of the physiological cartilage matrix, major target of cartilage degeneration, major tool in cartilage repair. Adv Drug Deliv Rev 2003; 55: 1569-93.
123. Brittberg M, Peterson L. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med 1994; 331: 889-95.
124. Wakitani S, Goto T, Pineda SJ, Young RG, Mansour JM, Caplan AI, et al. Mesenchymal cell-based repair of large, full-thickness defects of articular cartilage. J Bone Joint Surg 1994; 76: 579-92.
125. Nehrer S, Breinan HA, Spector M. Matrix collagen type and pore size influence behavior of seeded canine chondrocytes. Biomaterials 1997; 18: 769-76.
126. Frenkel SR, Toolan B, Pachence JM. Chondrocyte transplantation using a collagen bilayer matrix for cartilage repair. J Bone Joint Surg 1997; 79B: 831-6.
127. Li WJ, Jiang YJ, Tuan RS. Chondrocyte phenotype in engineered fibrous matrix is regulated by fiber size. Tissue Eng 2006; 12: 1775-85.
128. Matthews JA, Boland ED, Wnek GE, Bowlin GL. Electrospinning of collagen type II: a feasibility study. J Bioact Comp Polym 2003; 18: 125-34.
129. Shields KJ, Beckman MJ, Wayne JS. Mechanical properties and cellular proliferation of electrospun collagen type II. Tissue Eng 2004; 10: 1510-7.
130. Pavesio A, Abatangelo G, Marcacci M. Hyaluronan-based scaffolds (Hyalograft C) in the treatment of knee cartilage defects: preliminary clinical findings. Novartis Found Symp 2003; 249: 203-17.
131. Bachmann G, Steinmyer J. MRI in the follow-up of matrix supported autologous chondrocyte transplantation and microfracture. Radiologe 2004; 44: 773-82.
132. Ronga M, Grassi FA, Bulgheroni P. Arthroscopic autologous chondrocyte implantation for the treatment of a chondral defect in the tibial plateau of the knee. Arthroscopy 2004; 20: 79-84.
133. Cummings CL, Gawlitta D, Nerem RM, Stegemann JP. Properties of engineered vascular constructs made from collagen, fibrin, and collagen-fibrin mixtures. Biomaterials 2004; 25: 3699-706.
134. Shinoka T, Shum-Tim D, Mayer J. Creation of viable pulmonary artery autografts through tissue engineering. J Thorac Cardiovasc Surg 1998; 115: 536-45.
135. Tyan YC, Liao JD, Weng CC. Assessment and characterization of degradation effect for the varied degrees of ultra-violet radiation onto the collagen-bonded polypropylene non-woven fabric surfaces. Biomaterials 2002; 23: 65-76.
136. Venugopal J, Zhang YZ, Ramakrishna S. Fabrication of modified and functionalized polycaprolactone nanofiber scaffolds for vascular tissue engineering. Nanotechnology 2005; 16: 2138-42
137. He W, Yong T, Teo WE, Ramakrisna S. Fabrication and endothelialization of collagen-blended biodegradable polymer nanofibers: potential vascular graft for blood vessel tissue engineering. Tissue Eng 2005; 11: 1574-88.
138. Mo XM, Xu CY, Kotaki M, Ramakrishna S. Electrospun P(LLA-CL) nanofiber: a biomimetic extracellular matrix for smooth muscle cell and endothelial cell proliferation. Biomaterials 2004; 25: 1883-90.
139. Theron A, Zussman E, Yarin AL. Electrostatic field-assisted alignment of electrospun nanofibres. Nanotechnology 2001; 12: 384-90.
140. Boland ED, Matthews JA, Pawlowski KJ, Simpson DG, Wnek GE, Bowlin GL. Electrospinning collagen and elastin: preliminary vascular tissue engineering. Front Biosci 2004; 9: 1422-32.
141. Ratcliffe A. Tissue engineering of vascular grafts. Matrix Biol 2000; 19: 353-7.
142. He W, Yong T, Teo WE, Ramakrishna S. Biodegradable polymer nanofiber mesh to maintain functions of endothelial cells. Tissue Eng 2006; 12: 2457-66.
143. Noble J, Munro CA, Prasad VSSV, Midha R: Analysis of upper and lower extremity peripheral nerve injuries in a population of patients with multiple injuries. J Trauma 1998; 45: 116-22.
144. Schmidt CE, Leach JB. Neural tissue engineering: strategies for repair and regeneration. Ann Biomed Eng 2003; 5: 293-347.
145. Stoll G, Muller HW. Nerve injury, axonal degeneration and neural regeneration: basic insights. Brain Pathol 1999; 9: 313-25.
146. Stang F, Fansa H, Keilhoff G. Structural parameters of collagen nerve grafts influence peripheral nerve regeneration. Biomaterials 2005; 26: 3083-91.
147. Evans GR, Patrick Jr. CW Bioactive poly(L-lactic acid) conduits seeded with schwann cells for peripheral nerve regeneration. Biomaterials 2002; 23: 841-8.
148. Yang F, Murugan R, Wang S, Ramakrishna S. Electrospinning of nano/micro scale poly(L-lactic acid) aligned fibers and their potential in neural tissue engineering. Biomaterials 2005; 26: 2603-10.
149. Nakamura T, Inada S, Shimizu Y. Experimental study on the regeneration of peripheral nerve gaps through a polyglycolic acid-collagen (PGA-collagen) tube. Brain Res 2004; 1027: 18-29.
150. Den Dunnen WFA, Meek MF, Robinson PH, Schakernraad JM. Peripheral nerve regeneration through P(DLLA-epsilon-CL) nerve guides. J Mater Sci Mater Med 1998; 9: 811-4.
151. Bini TB, Gao S, Ramakrishna S. Peripheral nerve regeneration by microbraided poly(L-lactide-co-glycolide) biodegradable polymer fibers. J Biomed Mater Res 2004; 68A: 286-95.
152. Pego AP, Poot AA, Grijpma DW, Feijen J. Copolymers of trimethylene carbonate and caprolactone for porous nerve guides: synthesis and properties. J Biomater Sci Polym Edn 2001; 12: 35-53.
153. Verreck G, Chun Y, Li Y, Kataria R, Peeters J, Brewester ME. Preparation and physicochemical characterization of biodegradable nerve guides containing the nerve growth agent sabeluzole. Biomaterials 2005; 26: 1307-15.
154. Rodriquez FJ, Gomez N, Perego G, Navarro X. Highly permeable polylactide-caprolactone nerve guides enhance peripheral nerve regeneration through long gaps. Biomaterials 1999; 20: 1489-500.
155. Evans GR, Brandt, Patrick Jr. CW. In vivo evaluation of poly(L-lactic acid) porous conduits for peripheral nerve regeneration. Biomaterials 1999; 20: 1109-15.
156. Widmer MS, Gupta PK, Lu L, Evans GR, Mikos AG. Manufacturing of porous biodegradable polymer conduits by an extrusion process for guided tissue regeneration. Biomaterials 1998; 19: 1945-55.
157. Hall S. Nerve repair: a neurobiologist's review. J Hand Surg 2001; 26B: 129-36.
158. Ide C. Peripheral nerve regeneration. Neurosci Res 1996; 25: 101-21.
159. Lundborg G, Dahlin L, Danielsen N, Zhao Q. Trophism, tropism, and specificity in nerve regeneration. J Reconstr Microsurg 1994; 10: 345-54.
160. Yoshii S, Oka MJ. Collagen filaments as a scaffold for nerve regeneration. J Biomed Mater Res 2001; 56: 400-5.
161. Letonurneau PC, Condic ML, Snow DM. Interactions of developing neurons with the extracellular matrix. J Neurosci 1994; 14: 915-28.
162. Labrador LO, Navarro X. Influence of collagen and laminin gels concentration on nerve regeneration after resection and tube repair. Exp Neurol 1998;149: 243-52.
163. Miller C, Shanks H, Mallapragada S. Oriented schwann cell growth on micropatterned biodegradable polymer substrates. Biomaterials 2001; 22: 1263-9.
164. Zhang Z, Yoo R, Tresco P. Neurite outgrowth on well-characterized surfaces: preparation and characterization of chemically and spatially controlled fibronectin and RGD substrates with good bio-activity. Biomaterials 2005; 26: 47-61.
165. Camarata PJ, Suryanarayanan R, Ebner TJ. Sustained release of nerve growth factor from biodegradable polymer microspheres. Neurosurgery 1992; 30: 313-9.
166. Whitworth RA, Brown RA, Terenghi GJ. Nerve growth factor enhances nerve regeneration through fibronectin grafts. Hand Surg (Br) 1996; 21: 514-22.
167. Rich KM, Alexander JC, Hollowell JP. Nerve growth factor enhances regeneration through silicone chambers. Exp Neurol 1989; 105: 162-70.
168. Yuan Y, Zhang P, Ynag Y, Wang X, Gu X. The interaction of schwann cells with chitosan membranes and fibers in vitro. Biomaterials 2004; 25: 4273-8.
169. Matsuda A, Kobayashi H, Tanaka J. Immobilization of laminin peptide in molecularly aligned chitsoan by covalent bonding. Biomaterials 2005; 26: 2273-9.
170. Cheng M, Deng J, Yang F, Gong Y, Zhao N, Zhang X. Study on physical properties and nerve cell affinity of composite films from chitosan and gelatin solutions. Biomaterials 2003; 24: 2871-80.
171. Mingyu CK, Gong J, Zhang XZ. Surface modification and characterization of chitosan film blended with poly-L-lysine. Biomater Appl 2004; 19: 59-62.
172. Borkenhagen M, Clemence JF, Aebischer P. Three dimensional extracellular matrix engineering in the nervous system. J Biomed Mater Res 1998; 40: 392-400.
173. Helder MN, Knippenberg M, Klein-Nulend J, Wuisman PIJM. Stem cells from adipose tissue allow challenging new concepts for regenerative medicine. Tissue Eng 2007; 13: 1799-808.
174. http://stemcells.nih.gov/info/basics/basics1.asp
175. Guillot PV, Cui W, Fisk NM, Polak DJ. Stem cell differentiation and expansion for clinical applications of tissue engineering. J Cell Mol Med 2007; 11: 935-44.
176. Commission on Life Sciences, Stem cells and the future of regenerative medicine. Washington (D. C.): National Academy Press, 2002; 94.
177. Petit-Zeman S. Regenerative medicine. Nat Biotechnol 2001; 19: 201-6.
178. Osiris Therapeutics (2005) Osteocel. Available: http://www.osiristx.com/products_osteocel. 2006.
179. Sangwan VS, Vemuganti GK, Singh S, Balasubramanian D. Successful reconstruction of damaged ocular outer surface in humans using limbal and conjuctival stem cell culture methods. Biosci Rep 2003; 23: 169-74.
180. World Health Organization (2005) State of the world's sight. VISION 2020: The right to sight, 1999-2005. Available: http://www.who.int/pbd/blindness/vision_2020/ v2020_therighttosight.pdf.2006.
181. Park KS, Lee YS, Kang KS. In vitro neuronal and osteogenic differentiation of mesenchymal stem cells from human umbilical cord blood. J Vet Sci 2006; 7: 343-8.
182. Cuneo S, Rangel R, Gallardo E, Muniz M. Stem cells from umbilical cord blood as a source for future genetic and therapeutic uses in patients from future genetic and therapeutic uses in patients from IVF donation programs. Int Cong Series 2004; 1271: 167-70.
183. de Vries EGE, Vellenga E, Kluin-Nelemans JC, Mulder NH. The happy density of frozen haematopoietic stem cells: from immature stem cells to mature applications. Eur J Cancer 2004; 40: 1987-92.
184. Chua KN, Chai C, Ramakrishna S, Leong KW, Mao HQ. Surface-aminated clectrospun nanofibers enhance adhesion and expansion of human umbilical cord blood hematopoietic stem/progenitor cells. Biomaterials 2006; 27: 6043-51.
185. Greco F, Vicent MJ. Polymer-drug conjugates: current status and future trends. Front Biosci 2008; 13:2744-56.
186. Patel PD, Dand N, Hirlekar RS, Kadam VJ. Drug loaded erythrocytes: as novel drug delivery system. Curr Pharm Des 2008; 14(1): 63-70.
187. Patil RR, Guhagarkar SA, Devarajan PV. Engineered nanocarriers of doxorubicin: a current update. Crit Rev Ther Drug Carrier Syst 2009; 25(1):1-61.